Abstract | PURPOSE: METHODS: In 20 adult patients with poor graft function ( PGF defined as transfusion-dependent platelet counts <20,000/µl, or leukocytes <1500/µl, or transfusion-dependent anemia) and variable causes of PGF after allogeneic PBSCT, immunomagnetically selected CD34(+) stem cell boosts (SCB) from matched unrelated (n = 8), mismatched unrelated (n = 11) or haploidentical (n = 1) donors were applied without prior conditioning. RESULTS: Patients received a median of 4.6 × 10(6) CD34(+) cells per kilogram bodyweight (1.9-9.1 × 10(6)) and low T cell numbers (median 0.2 × 10(4), range 0.04-0.6 × 10(4)). All patients showed responses in at least one hematopoietic lineage. Engraftment for platelets, leukocytes and hemoglobin was 88, 88 and 100 % after a median of 14, 13 and 18 days, respectively. With regard to the complete cohort, 90 % (n = 18) showed an increase in platelets (median 76,500/µl, range -7000 to 223,000/µl), 95 % (n = 19) had an increase in leukocytes (median 3110/µl, range 150-13,740/µl) and 90 % (n = 18) improved with regard to hemoglobin (median 1.9 g/dl, range -0.9 to 5.1 g/dl). Due to effective T cell depletion, only one patient developed graft versus host disease (GvHD, grade III) after SCB. Patients were followed for a median of 7.5 months (1-74 months) with 11 patients being alive and disease free with normalized peripheral blood counts at the end of follow-up. CONCLUSIONS: CD34(+)-selected SCB are safe and effective and can durably improve PGF even in patients receiving grafts from unrelated matched or mismatched donors with low incidence of GvHD.
|
Authors | Sebastian P Haen, Michael Schumm, Christoph Faul, Lothar Kanz, Wolfgang A Bethge, Wichard Vogel |
Journal | Journal of cancer research and clinical oncology
(J Cancer Res Clin Oncol)
Vol. 141
Issue 12
Pg. 2241-51
(Dec 2015)
ISSN: 1432-1335 [Electronic] Germany |
PMID | 26272482
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Antigens, CD34
(immunology)
- Cohort Studies
- Female
- Follow-Up Studies
- Graft Survival
- Graft vs Host Disease
(etiology, mortality, prevention & control)
- Hematologic Neoplasms
(complications, therapy)
- Histocompatibility
- Humans
- Leukapheresis
- Male
- Middle Aged
- Peripheral Blood Stem Cell Transplantation
(adverse effects)
- Prognosis
- Stem Cells
(cytology, immunology)
- Survival Rate
- Tissue Donors
- Transplantation Conditioning
- Transplantation, Homologous
- Unrelated Donors
- Young Adult
|